Sign in

CIK 0001590750

  • Large accelerated filer

Viridian Therapeutics, Inc.\DE

Sign in to watch
Ticker
VRDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
471187261
Phone
+1 617-272-4600
Business address
221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
Former names
MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$348,194
in 1 filing

Net −$348,194. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Tousignant Jennifer −$348K Chief Legal Officer sold 100% of stake

Reading 15 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-05-11 Fairmount Funds Management LLC Director Purchase +1,176,470 $17.00 $20.0M 5,090,928
2025-10-23 Fairmount Funds Management LLC Director Purchase +454,545 $22.00 $10.0M 3,914,458
2025-06-10 Fairmount Funds Management LLC Director Option exercise +12,500 $12.31 $154K 3,459,913
2025-06-10 Fairmount Funds Management LLC Director Option exercise · Stock Option (Right to Buy) −12,500 0
2025-06-09 Fairmount Funds Management LLC Director Option exercise +1,600 $7.80 $12K 3,447,413
2025-06-09 Fairmount Funds Management LLC Director Option exercise · Stock Option (Right to Buy) −1,600 0
2024-09-13 Fairmount Funds Management LLC Director Purchase +1,600,000 $18.75 $30.0M 3,445,813
2024-03-28 Fairmount Funds Management LLC Director Other disposition −5,859 0
2024-03-28 Fairmount Funds Management LLC Director Other acquisition +5,859 1,845,813
2024-03-28 Fairmount Funds Management LLC Director Other disposition · Series A Non-Voting Convertible Preferred Stock −21,999 0
2024-03-28 Fairmount Funds Management LLC Director Other acquisition · Series A Non-Voting Convertible Preferred Stock +21,999 133,191
2024-01-22 Fairmount Funds Management LLC Director Purchase +476,190 $21.00 $10.0M 1,839,954
2023-10-30 Fairmount Funds Management LLC Director Grant or award · Series B Non-Voting Convertible Preferred Stock +48,463 $825.37 $40.0M 48,463
2022-08-17 Fairmount Funds Management LLC Director Purchase +425,531 $23.50 $10.0M 1,363,764
2021-09-21 Fairmount Funds Management LLC Director Purchase +909,000 $11.00 $10.0M 938,233
2020-10-30 Fairmount Funds Management LLC Director Purchase · Series A Non-Voting Convertible Preferred Stock +5,494 $465.96 $2.6M 21,999
2020-10-30 Fairmount Funds Management LLC Director Purchase · Series A Non-Voting Convertible Preferred Stock +28,843 $465.96 $13.4M 111,192
2020-10-27 Fairmount Funds Management LLC Director Other acquisition +87,891 87,891
2020-10-27 Fairmount Funds Management LLC Director Other acquisition +438,502 438,502
2020-10-27 Fairmount Funds Management LLC Director Other acquisition · Series A Non-Voting Convertible Preferred Stock +16,505 16,505

Page 1 of 2 · 21 trades